Methylation defects are relatively new genetic disorders and they are thoroughly being studied and treated around the world. Methylation is a vital part of our bodies’ natural process of detoxification. Methylation also regulates neurotransmitters and hormones. Individuals with a methylenetetrahydrofolate reductase (MTHFR) mutation have a decreased ability to convert folate–or folic acid–into a usable form. According to research, over half of the population may have an MTHFR gene mutation. There are many variations of this mutation that all point to the same general problem, an incorrect conversion process of folate within the body.
Symptoms of MTHFR mutation can include anxiety, depression, blood sugar problems, autism, chronic fatigue syndrome, heart issues, and more.